203
Participants
Start Date
June 27, 2014
Primary Completion Date
July 4, 2017
Study Completion Date
July 4, 2017
Canakinumab
Canakinumab solution for subcutaneous injection in vial which contained 150mg/mL canakinumab in 1 mL solution.
Placebo
Matching placebo to canakinumab solution for subcutaneous injection
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Brussels
Novartis Investigative Site, Edegem
Novartis Investigative Site, Leuven
Novartis Investigative Site, Hasselt
Novartis Investigative Site, Liège
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Genova
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Brescia
Novartis Investigative Site, Pavia
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Nîmes
Novartis Investigative Site, El Palmar
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Trieste
Novartis Investigative Site, Cleveland
Novartis Investigative Site, Essen
Novartis Investigative Site, Valencia
Novartis Investigative Site, Ann Arbor
Novartis Investigative Site, Petah Tikva
Novartis Investigative Site, Florence
Novartis Investigative Site, Saint Augustin
Novartis Investigative Site, Bron
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Paris
Novartis Investigative Site, Napoli
Novartis Investigative Site, München
Novartis Investigative Site, Germering
Novartis Investigative Site, Los Angeles
Novartis Investigative Site, Sciacca
Novartis Investigative Site, Le Kremlin-Bicêtre
Novartis Investigative Site, Messina
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Rostov-on-Don
Novartis Investigative Site, Haifa
Novartis Investigative Site, Haifa
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Jerusalem
Novartis Investigative Site, Calgary
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Galway
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Sakyo-ku
Novartis Investigative Site, Niigata
Novartis Investigative Site, Nijmegen
Novartis Investigative Site, Utrecht
Novartis Investigative Site, Esplugues de Llobregat
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Ankara
Novartis Investigative Site, Leeds
Novartis Investigative Site, London
Novartis Investigative Site, London
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY